Hepatitis

  • Most Topular Stories

  • Portland berry grower calls for greater tests on imported foods

    Hepatitis News
    27 Feb 2015 | 6:30 pm
    A PORTLAND berry grower has called for improved quality controls in the wake of the hepatitis A outbreak linked to frozen fruit imported from China. Peter Cutler , from Portland Strawberries, and picker James Corbett hard at work to meet the demand for their produce.
  • Stellate cells in the liver control regeneration and fibrosis

    Liver Disease / Hepatitis News From Medical News Today
    26 Feb 2015 | 12:00 am
    Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem.
  • Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.

    MedWorm: Hepatitis B
    27 Feb 2015 | 3:13 am
    Conclusions: HBsAg quantification using IRMA might be useful for discriminating different CHB phases and different stages of chronic liver disease. PMID: 25717049 [PubMed - as supplied by publisher] (Source: Gut and Liver)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
  • Gilead Sciences, Inc. Continues To Lead The Hepatitis C Market; Its HCV Drugs ... - Bidness ETC

    hepatitis - Google News
    28 Feb 2015 | 8:29 am
    Bidness ETCGilead Sciences, Inc. Continues To Lead The Hepatitis C Market; Its HCV Drugs Bidness ETCAccording to the latest data published by Symphony Health Solutions, as reported by Bloomberg Intelligence, Gilead's hepatitis C franchise saw a 4.5% growth for the week ending February 20. The said franchise comprises of two blockbuster treatments
  • Hepatitis C Quiz

    About.com Hepatitis: What's Hot Now
    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Do you understand the basics of hepatitis C? Take this short quiz to test your knowledge on all the essential hepatitis C information, including symptoms, diagnosis, treatment and prevention.
  • add this feed to my.Alltop

    MedWorm: Hepatitis B

  • Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.

    27 Feb 2015 | 3:13 am
    Conclusions: HBsAg quantification using IRMA might be useful for discriminating different CHB phases and different stages of chronic liver disease. PMID: 25717049 [PubMed - as supplied by publisher] (Source: Gut and Liver)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
  • Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case‐control study in The Gambia

    27 Feb 2015 | 2:58 am
    ConclusionsCompared to controls, HCC cases had earlier birth order, a proxy for young maternal age and maternal HBV viraemia at birth. This finding suggests that in chronic HBV carriers perinatal mother‐to‐infant transmission may increase HCC risk more than horizontal transmission. Providing HBV vaccine within 24 hours of birth to interrupt perinatal transmission might reduce the incidence of HCC in The Gambia.This article is protected by copyright. All rights reserved. (Source: Liver International)
  • Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

    26 Feb 2015 | 3:00 pm
    Conclusion: Although the primary endpoint was not reached, 24 weeks of Peg‐IFN add‐on therapy led to a higher proportion of HBeAg response, compared to ETV monotherapy. Add‐on therapy resulted in more viral decline and appeared to prevent relapse after stopping ETV. Hence, Peg‐IFN add‐on therapy may facilitate the discontinuation of nucleos(t)ide analogs. (Hepatology 2014) (Source: Hepatology)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
  • Retinoids Reduced HBV Susceptibility by Down-regulating NTCP [Microbiology]

    26 Feb 2015 | 3:00 pm
    Sodium taurocholate cotransporting polypeptide (NTCP) is an entry receptor for hepatitis B virus (HBV) and is regarded as one of the determinants that confer HBV permissiveness to host cells. However, how host factors regulate the ability of NTCP to support HBV infection is largely unknown. We aimed to identify the host signaling that regulated NTCP expression and thereby permissiveness to HBV. Here, a cell-based chemical screening method identified that Ro41-5253 decreased host susceptibility to HBV infection. Pretreatment with Ro41-5253 inhibited the viral entry process without affecting…
  • Impact of hepatitis B and C infections in renal transplantation

    26 Feb 2015 | 3:00 pm
    Publication date: October–December 2014 Source:Indian Journal of Transplantation, Volume 8, Issue 4 Author(s): Radhika Chemmangattu Radhakrishnan , Gopal Basu , Santhosh Varughese , Anjali Mahopatra , Anna. T. Valson , Suceena Alexander , Shibu Jacob , Harish Ratnakarrao Pathak , Uday Zaccharia , Priya Abraham , V. Tamilarasi (Source: Indian Journal of Transplantation)
 
  • add this feed to my.Alltop

    hepatitis - Google News

  • Gilead Sciences, Inc. Continues To Lead The Hepatitis C Market; Its HCV Drugs ... - Bidness ETC

    28 Feb 2015 | 8:29 am
    Bidness ETCGilead Sciences, Inc. Continues To Lead The Hepatitis C Market; Its HCV Drugs Bidness ETCAccording to the latest data published by Symphony Health Solutions, as reported by Bloomberg Intelligence, Gilead's hepatitis C franchise saw a 4.5% growth for the week ending February 20. The said franchise comprises of two blockbuster treatments
  • Hepatitis C Infections in Hospitals Show Need for Tight Infection Control ... - WebMD

    27 Feb 2015 | 1:25 pm
    Hepatitis C Infections in Hospitals Show Need for Tight Infection Control WebMDIn one case, two New Jersey patients (one of them had hepatitis C) received an injection of the anesthetic propofol from the same medication cart. In the other instance, two Wisconsin patients (one of them had hepatitis C) received kidneys that had and more »
  • Doctor Panel to Weigh Hepatitis C Drugs' Costs in Guidelines - Bloomberg

    27 Feb 2015 | 1:06 pm
    Bidness ETCDoctor Panel to Weigh Hepatitis C Drugs' Costs in GuidelinesBloomberg(Bloomberg) -- An influential advisory panel of doctors and health experts will for the first time address the cost-effectiveness of pricey hepatitis C drugs in updated guidelines that may change prescribing and coverage for the medicines. The 30 Gilead dodges billions in taxes as money rolls in from hepatitis C drugsSanta Cruz SentinelGilead Taking Giant Leap To Serve The Hepatitis C Market Of Developing GuruFocus.com (registration)all 44 news articles »
  • Legendary Cannabis Breeder Is Raising $95000 For Hepatitis C Treatment - Medical Jane

    27 Feb 2015 | 11:18 am
    Medical JaneLegendary Cannabis Breeder Is Raising $95000 For Hepatitis C TreatmentMedical JaneThe man responsible for many of the world's most popular strains of marijuana, as well as the founding father of the Dutch Seed Banks, has been diagnosed with Hepatitis C and is asking for your help in raising funds and awareness for his treatment.
  • At EPO, Patent Oppositions To High-Priced Gilead Hepatitis C Drug Pile Up - Intellectual Property Watch

    27 Feb 2015 | 10:42 am
    At EPO, Patent Oppositions To High-Priced Gilead Hepatitis C Drug Pile UpIntellectual Property WatchAccording to a public health advocacy group, there are now as many as 10 oppositions filed at the European Patent Office against the Gilead company's patent on sofosbuvir, a treatment for hepatitis C. The group has compiled a table showing the filings
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • Hepatitis C Quiz

    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Do you understand the basics of hepatitis C? Take this short quiz to test your knowledge on all the essential hepatitis C information, including symptoms, diagnosis, treatment and prevention.
  • Can You Get Hepatitis C from Getting a Tattoo?

    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Is there a link between hepatitis and tattoos? Yes, there is and here's how you can protect yourself.
  • Preventing Hepatitis C

    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Hepatitis C infection is a worldwide problem that can easily become your problem, too. Astonishingly, about 170 million people in the world suffer from this preventable infection. Since chronic hepatitis C can lead to many serious health problems, such as liver cirrhosis and liver cancer, it's important to know and understand how to protect yourself through prevention.
  • Information about Peginterferon

    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Peginterferon is a powerful antiviral drug treatment for chronic hepatitis B and C. Here is information on side effects, costs, effectiveness and warnings.
  • Can You Get Hepatitis C By Having Sex?

    hepatitis.guide@about.com
    28 Feb 2015 | 3:12 am
    Is hepatitis C spread by having sex? Yes, but it's not as easy as you think.
 
  • add this feed to my.Alltop

    About.com Hepatitis: Most Popular Articles

  • Fibrosis

    28 Feb 2015 | 4:22 am
    Definition of Fibrosis. Hepatitis.
  • Ways to Make Hepatitis Patients Feel Special on...

    28 Feb 2015 | 4:22 am
    Have you ever considered what could be the right birthday gifts for hepatitis patients? Read this to know more.
  • How Do I Know It's Hepatitis?

    28 Feb 2015 | 4:22 am
    The symptoms of hepatitis vary depending on what type of the disease a person has. It is also very hard to know if you have the disease without consulting a doctor.
  • Acetaminophen

    28 Feb 2015 | 4:22 am
    Definition of Acetaminophen. Hepatitis.
  • What Is Hepatitis C Infection

    28 Feb 2015 | 4:22 am
    Hepatitis C is a major cause of liver disease for almost 170 million people in the world and almost 4 million in the United States. The disease can be relatively simple for some, but for most it leads to a chronic condition of cirrhosis and other complications.
  • add this feed to my.Alltop

    Hepatitis Central

  • Warning: Food Dyes Pose Liver-Related Risks

    Nicole Cutler L.Ac.
    27 Feb 2015 | 6:02 am
    Impact of Food Color on the Liver Don’t depend on the FDA for your safety. Know which synthetic food dyes may be harmful to your liver. Many of today’s food and beverages represent a striking color of the rainbow, raising their aesthetic appeal. Frequently, manufacturers resort to color additives to achieve the desired, appetizing hue. The U.S. Food and Drug Administration (FDA) is tasked with overseeing the safety and appropriate use of food color additives, but may fall short in protecting the long term wellness of those with a challenged liver. A color additive is any dye, pigment or…
  • Is Gluten Harmful to Those with Hepatitis C?

    Nicole Cutler L.Ac.
    19 Feb 2015 | 7:46 am
    Gluten-free foods have been increasing in popularity – fueled by diagnoses of Celiac disease and gluten sensitivities. Celiac disease is an autoimmune disorder where the body reacts to gluten, a protein found in wheat, barley, rye, spelt, triticale and sometimes oats. Celiac disease is estimated to affect at least 5 percent of the population, but gluten sensitivity – or intolerance – is much more common, impacting up to 18 million people in the U.S. Although few physicians have yet to make the connection, a liver battling the Hepatitis C virus might be excessively burdened by gluten…
  • How to Slow Down Liver Fibrosis

    The Editors at Hepatitis Central
    10 Feb 2015 | 11:28 am
    Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C By Michael R. Page, PharmD, RPh February 06, 2015 In 2 recent studies, statins and aspirin have been associated with lower rates of progression of liver fibrosis in patients with hepatitis C. Strategies for slowing the rate of progression of liver fibrosis are important for these reasons: (1) the high cost of treatment for hepatitis C; and (2) updated guidelines that recommend prioritizing treatment to sicker patients and postponing treatment in other groups.1-4 Statins In animal models, statins have been shown to slow…
  • Surprising Nutritional Support for Hepatitis C

    Nicole Cutler L.Ac.
    29 Jan 2015 | 9:45 am
    There are so many suggestions out there for how you can stay healthy with Hepatitis C. If you listened to every possible source, your day could easily be filled with a dizzying parade of countless vitamins, supplements, alternative treatments, strict dietary guidelines, exercise routines, meditation practices, and so on and so forth. Wouldn’t it be nice if some type of food product covered a bunch of these bases in one convenient step? UltraNourish, a new nutritional shake, has answered the liver and general health call for simplification. Protein Shakes Aren’t Just for Bodybuilders The…
  • Are Treatments for HCV Being Over-Promoted?

    The Editors at Hepatitis Central
    26 Jan 2015 | 9:44 am
    Overdoing Hepatitis C Screenings May Be Bad for your Health By Dianne Depra, Tech Times | January 15 The Centers for Disease Control and Prevention (CDC) in 2012 recommended hepatitis C screenings for anyone born from 1945 to 1965. In 2014, the World Health Organization made the same recommendation, but a group of scientists are not convinced that mass screenings for the age group are effective or even necessary. In a piece published in the journal BMJ, Ronald Koretz, Kenneth Lin, John Ioannidis and Jeanne Lenzer questioned the recommended screening for hepatitis C, concerned that it has no…
 
  • add this feed to my.Alltop

    Hepatitis C Treatment News

  • DJIA Index Notches 5.6% Gain in February

    27 Feb 2015 | 3:43 pm
    … market. High-margin specialty drugs are prescription medications that treat complex, … priciest high-margin specialty drugs include Soliris, developed by Alexion Pharmaceuticals, … high-margin specialty drugs comes from makers of hepatitis C treatments. An April …
  • Ways to Treat Depression That Aren’t Antidepressants

    27 Feb 2015 | 2:43 pm
    … psychiatrist who specializes in treatment-resistant depression at Lenox … you differently?” Anti-inflammatory medications. Inflammation has been … Another class of anti-inflammatory drugs, called cytokine inhibitors, … linked to chronic hepatitis C. “If you could …
  • Hepatitis C Infections in Hospitals Show Need for Tight Infection Control Practices

    27 Feb 2015 | 1:25 pm
    … hepatitis C) received an injection of the anesthetic propofol from the same medication … percent of those with chronic hepatitis C eventually develop acute disease, which can … and Prevention for more on hepatitis C. This article: Copyright © 2015 HealthDay …
  • Five things for pharma marketers to know: Friday, February 27

    27 Feb 2015 | 10:11 am
    … could…increase the risk of developing Alzheimer's, if … due to more favorable tax treatments outside the US. The news … of 153) with hepatitis C in a Phase-III clinical trial. BMS stated that … CDC recommends the vaccination without FDA approval for use in …
  • Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® and Harvoni® in India

    27 Feb 2015 | 9:55 am
    … Hepatitis C is a growing public health concern, particularly in developing … Food and Drug Administration (FDA) in December 2013 … treatment option in the World Health Organization's first hepatitis C treatment … and several brand medications. In addition, we …
  • add this feed to my.Alltop

    Hepatitis News

  • Cerus Squeezes Healthy Blood From A Stone

    28 Feb 2015 | 10:59 am
    Blood transfusions are extremely common. One in every seven people entering a hospital will need a blood transfusion, and so will 18% of the millions of cancer patients globally.
  • Food label revamp will tell consumers where products originated, were processed and packed

    28 Feb 2015 | 6:49 am
    Amid concern over an outbreak of hepatitis A linked to frozen berries, Australia's food packaging laws are set for a long-mooted overhaul. What has driven the change, and what might it mean for consumers? Darren Gray explains.
  • Hepatitis-drug guidelines will be revisited

    27 Feb 2015 | 10:45 pm
    An influential advisory panel of doctors and health experts will for the first time address the cost-effectiveness of pricey hepatitis C drugs in updated guidelines that may change prescribing and coverage for the medicines. The 30-member panel is a joint effort by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America, which together represent more than 10,000 physicians, health workers and scientists.
  • Portland berry grower calls for greater tests on imported foods

    27 Feb 2015 | 6:30 pm
    A PORTLAND berry grower has called for improved quality controls in the wake of the hepatitis A outbreak linked to frozen fruit imported from China. Peter Cutler , from Portland Strawberries, and picker James Corbett hard at work to meet the demand for their produce.
  • Hepatitis C Infections in Hospitals Show Need for Tight Infection Control Practices

    27 Feb 2015 | 2:31 pm
    Two cases of hepatitis C infection that occurred during routine surgeries highlight the need for hospitals to tighten infection control to prevent more transmissions, officials said Friday. In one case, two New Jersey patients received an injection of the anesthetic propofol from the same medication cart.
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Mecklenburg County Health Offering Hepatitis A Vaccines

    Bill Marler
    17 Feb 2015 | 3:12 pm
    Karen Garloch of the Charlotte Observer reports that the Mecklenburg County Health Department is offering Hepatitis A vaccine clinics for patrons who visited the Dogwood Southern Table and Bar during dinner hours on Feb. 4-Feb. 10. A Dogwood employee who developed a hepatitis A infection did not prepare food, but was responsible for cleaning silverware and glasses and delivering food to tables. The employee did not work at the restaurant after Feb. 10, so there is no risk to patrons who ate at there after that date. Health officials are encouraging people who visited the restaurant on Feb. 4…
  • Hepatitis A Warning: Dogwood Southern Table and Bar in Charlotte, N.C.

    Bill Marler
    16 Feb 2015 | 11:52 am
    A restaurant employee in Charlotte, NC, has tested positive for the Hepatitis A virus, according to the Mecklenburg County Health Department. Health officials said the individual worked at the Dogwood Southern Table and Bar in Charlotte. The employee did not prepare food, they said, but was responsible for cleaning and polishing silverware and glasses and delivering food to tables. Health department officials have advised staff members and patrons who visited the restaurant on the dates and times listed below that they may be at risk of developing the virus if they have not been vaccinated.
  • Nanna’s Frozen Mixed Berry Recalled in Australia Due to Hepatitis A

    Bill Marler
    14 Feb 2015 | 12:54 pm
    Victoria’s health department has urged consumers to dispose of 1kg packets of Nanna’s Frozen Mixed Berry, which are sold in major supermarkets including Woolworths, Coles and IGA stores. Nanna’s Frozen Mixed Berry 1kg packets shouldn’t be eaten if they have a best before date up to and including November 22, 2016. Four adults, three in Victoria and one in NSW, have contracted potentially deadly Hepatitis A after consuming the imported fruit. The health department has also told the company to recall the product, which is distributed by Patties in Victoria, but packed in…
  • Another Hepatitis A Illness Linked to Rosa’s Restaurant

    Bill Marler
    9 Jan 2015 | 5:34 pm
    Another Hepatitis A case is being reported by a person who ate at the same restaurant in Hamilton Township. Robbinsville Township health officials say the resident ate at Rosa’s Restaurant on 3442 South Broad Street during the time when a food handler reported having Hepatitis A. The patient works in Hamilton Township. However, health officials say coworkers at the job only have a negligible risk. The first case of Hepatitis A was confirmed last month in a worker at Rosa’s. In light of that, the township hosted a vaccination clinic at a local firehouse. Then last week health…
  • Hepatitis A Cases Linked in New Jersey Restaurant

    Bill Marler
    2 Jan 2015 | 7:47 am
    On Thursday, health officials in Hamilton, NJ, confirmed two more cases of Hepatitis A in the township about a month after a food service worker at Rosa’s Restaurant and Catering in Hamilton first became infected with the virus. Health officials said that an employee of the Hair Port Salon in Hamilton had been diagnosed with Hepatitis A infection. The employee has been released from the hospital and is recovering at home, they added. Staff and customers who visited the salon between Dec. 4 and Dec. 30 may be at risk of contracting the virus and should be vaccinated if they have not already…
 
  • add this feed to my.Alltop

    HCV New Drug Research

  • Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

    26 Feb 2015 | 2:13 pm
    Gilead avoids billions in U.S. taxes on its $1,000-a-pill drugBy Richard Rubin, Bloomberg NewsBloombergWASHINGTON — Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world's most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits overseas.The company reported foreign income before taxes of $8.2 billion for 2014, earning more in non-U.S. profits than it recorded in non-U.S. sales. The data released in a securities filing Wednesday suggest that Gilead is taking advantage of U.S. rules that let companies shift valuable…
  • Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study

    26 Feb 2015 | 2:07 pm
    Bristol hep C drug helps cure 97 pct of HIV coinfected patients-studyBY BILL BERKROTFri Feb 27, 2015 1:45am ISTFeb 26 (Reuters) - Ninety-seven percent of hepatitis C patients also infected with HIV were cured of the liver-destroying virus after 12 weeks of treatment with Bristol-Myers Squibb's daclatasvir and Gilead Sciences' Sovaldi, according to data from a study presented on Thursday.The results could help put Bristol's hepatitis C program back on track in the United States, following a setback last year.In the Ally-2 study, including new patients and those not helped by prior treatment,…
  • Gilead Announces SVR12 Rates From Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected With HIV‏

    26 Feb 2015 | 12:30 pm
    Title: Gilead Announces SVR12 Rates From Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected With HIVDate(s): 26-Feb-2015 3:15 PM- 96 Percent SVR12 Rate for Hepatitis C Genotypes 1 and 4 Among HIV-infected Patients on Antiretroviral Therapy -SEATTLE--(BUSINESS WIRE)--Feb. 26, 2015-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily single tablet regimen Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of genotypes 1 or 4 chronic hepatitis C virus (HCV) infection…
  • Herbal products and adverse effects on the liver

    26 Feb 2015 | 3:54 am
    Herbal products and adverse effects on the liverThe most recent issue of the Gastroenterology reviews adverse effects and mechanisms.Herbal products have been used for centuries among indigenous people to treat symptoms and illnesses.Recently, their use in Western countries has grown significantly, rivaling that of prescription medications. Dr Leonard Seeff and colleagues from Pennsylvania, USA report that herbal products are used mainly for weight loss, and bodybuilding purposes but also to improve well-being and symptoms of chronic diseases. Many people believe that because they are…
  • NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

    25 Feb 2015 | 4:25 am
    Two new drug treatments for hepatitis C have been approved for NHS use by the National Institute for Health and Care Excellence.25 February, 2015 | By Steve FordNICE has recommended sofosbuvir (Sovaldi) and simeprevir (Olysio) as treatment options for some people with chronic hepatitis C.Sofosbuvir and simeprevir are both oral antiviral drugs used to prevent hepatitis C viral replication in infected cells.The NICE guidance on sofosbuvir recommends its use in combination with ribavirin, with or without peginterferon alfa, as an option for some people with genotypes 1-6 chronic hepatitis…
Log in